Valotx
Helsinki, FI · Founded 2016 · 11 employees on LinkedIn · 1 known investors
Find your way into Valotx
Sign up to see every warm intro you have to Valotx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Valotx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ValoTx develops oncolytic virus-based immunotherapies that combine viral vector technology with peptide vaccination to treat cancer. The company leverages a patented platform to rapidly create personalized and disease-specific immunotherapies targeting multiple cancer types.
Investors · 1
CDP Venture Capitallisted by CDP Venture CapitalRoma
How we know: CDP Venture Capital's portfolio page · the VCSheet dataset · Not right? Tell us
Related companies · 4
ValoValo Health applies technology and data to drug discovery, working across the technology, biotech, and healthcare fields. It positions itself as a company focused on reshaping how new drugs are discovered.
Valora TherapeuticsValora Therapeutics is a biotech company developing antibody-lectin chimera (AbLec) therapeutics that target cell-surface glycans for immuno-oncology and immunotherapy applications. Its work builds on glycobiology and bioorthogonal chemistry research.
VialVial develops first- and best-in-class biologics — including RNA, antibody, and small molecule programs — using AI-driven target discovery, molecule design, and high-throughput experimental validation, focused on immunology and inflammatory disorders. It also runs programs through its own clinical trial platform for automated clinical trials.
Flagship PioneeringFlagship Pioneering is a firm that builds and funds companies in life sciences and related fields, describing itself as focused on breakthroughs for people and the planet.
Companies working in the same space as Valotx.
Frequently asked questions
- What does Valotx do?
- ValoTx develops oncolytic virus-based immunotherapies that combine viral vector technology with peptide vaccination to treat cancer. The company leverages a patented platform to rapidly create personalized and disease-specific immunotherapies targeting multiple cancer types.
- Who are Valotx's investors?
- Valotx's investors include CDP Venture Capital.
- Where is Valotx headquartered?
- Valotx is headquartered in Helsinki, FI.


